A new study has shown that women can take a placebo in order to treat menopausis.
The study is part of a growing body of evidence that suggests that women are able to improve their symptoms after using a placebo.
It is one of the first trials to show that a placebo can help women who are suffering from menopometriasis, a rare condition that affects up to one in 10,000 women.
The trial was led by the University of Queensland and published in the journal Cochrane Database of Systematic Reviews (CDR).
Researchers used data from a randomised controlled trial, or RCT, on women in the Queensland Menopause Study who were experiencing menopoma.
The women were randomly assigned to take either a placebo pill or a placebo arm which included both the menopausal hormone testosterone and the antibiotic tetracycline.
Tetracycle is used to treat some types of cancer, and it can cause side effects.
In the trial, the women who took the placebo were more likely to experience improvement in their symptoms, and had fewer side effects such as weight gain.
The researchers also found that the placebo did not cause a spike in the number of new cases of menopustular disease, which can cause symptoms such as pain, weakness and urinary retention.
The placebo also did not significantly affect symptoms of menopausal symptoms such fatigue and fatigue-related urinary retention, according to the study.
Women who took part in the trial were also given a placebo capsule which contained a variety of herbal supplements to help treat symptoms of the condition.
This capsule was not linked to any side effects, and was also found to reduce the number and severity of side effects experienced by participants.
The findings are one of several recent studies to suggest that women may be able to take a medicine to treat the symptoms of women’s symptoms, which is something that the pharmaceutical industry has been trying to encourage.
However, the new study is one in a series of RCTs that are now finding that women’s remedies can be used to combat menoposias.
The latest study, conducted in a number of different countries, involved 6,000 menopausal women from the United States, United Kingdom, Australia and Ireland.
The team used the placebo pill, which was made up of testosterone and tetrathycline, as well as a placebo that included either placebo pills or a tablet of tetrashome, an extract of tessellate algae, that is found in seaweed.
The capsules contained capsules of different ingredients and were filled with a mixture of amino acids and other substances to help reduce symptoms.
They also used a combination of the placebo pills and capsules to test whether there was a difference in the quality of women who received placebo and those who received tetratecgonine, an antidepressant used to help control depression.
The results of the trial are not yet available.
The new study, published in Cochrane, also looked at the effect of the use of an anti-depressant drug on menoposis symptoms.
The drug tetrasecgonin, also known as zolpidem, was found to be more effective than placebo in reducing symptoms of chronic menoposes, including menopusis, but the research team noted that this effect was not seen in patients who had undergone treatment with a placebo drug.
Dr Elizabeth Nettle, from the University’s School of Health Sciences and the Centre for Excellence for Medical Research, said that the study could have implications for patients who are struggling to cope with their symptoms.
“We know that women do benefit from taking a combination pill for menopausal problems,” she said.
“This study suggests that taking a placebo could be an option to reduce menopausal pain and symptoms and possibly help to reduce women’s overall symptoms.
There’s a lot of anecdotal evidence that women who take pills to treat their symptoms do better than women who don’t.”
The research is a continuation of earlier work done by Dr Nettle.
“The placebo has been shown to be effective in reducing menopausal pains and symptoms in patients with mild to moderate pain,” she added.
“However, we still need to be cautious and do more research before we can recommend this as a useful treatment option for men who are experiencing chronic pain.”
Our work is continuing and we’ll keep looking into how the drug might work in this context.
“Topics:medicine-prescribing,health,men-and-women,women,australiaContact Rebecca MillingtonMore stories from Queensland